Avondale Partners Downgrades TrueBlue (TBI) to Underperform
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $6.44 +2.22%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
Avondale Partners downgraded TrueBlue (NYSE: TBI) from Market Outperform to Underperform with a price target of $15.00 (from $20.00).
For an analyst ratings summary and ratings history on TrueBlue click here. For more ratings news on TrueBlue click here.
Shares of TrueBlue closed at $20.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades L'Oreal SA (OR:FP) (LRLCY) to Sell
- Evercore ISI Downgrades Inspire Medical Systems (INSP) to In Line
- ACM Research, Inc. (ACMR) PT Raised to $130 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Avondale PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
